Steward Partners Investment Advisory, LLC Immuno Gen, Inc. Transaction History

Steward Partners Investment Advisory, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$4.55 - $6.31 $81 - $113	-18 Reduced 15.25%	100 $0
Q3 2022 Nov 10, 2022	SELL	$4.48 - $6.47 $94 - $135	-21 Reduced 15.11%	118 $1,000
Q1 2022 May 02, 2022	BUY	$4.26 - $7.48 $166 - $291	39 Added 39.0%	139 $1,000
Q2 2021 Aug 13, 2021	SELL	$5.79 - $8.6 $20,699 - $30,745	-3,575 Reduced 97.28%	100 $1,000
Q1 2021 May 14, 2021	BUY	$6.5 - $10.53 $20,150 - $32,642	3,100 Added 539.13%	3,675 $29,000
Q4 2020 Feb 11, 2021	SELL	$3.7 - $7.66 $129 - $268	-35 Reduced 5.74%	575 $4,000
Q3 2020 Oct 30, 2020	SELL	$3.45 - $4.89 $207 - $293	-60 Reduced 8.96%	610 $2,000
Q3 2019 Oct 30, 2019	SELL	$2.22 - $3.39 $801 - $1,223	-361 Reduced 35.01%	670 $1,000
Q2 2019 Jul 25, 2019	BUY	$1.8 - $3.3 $1,855 - $3,402	1,031 New	1,031 $2,000
Q4 2018 Jan 15, 2019	SELL	$3.94 - $9.7 $5,910 - $14,549	-1,500 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$8.6 - $11.26 $2,648 - $3,468	308 Added 25.84%	1,500 $14,000
Q2 2018 Jul 20, 2018	BUY	$9.52 - $12.15 $6,007 - $7,666	631 Added 112.48%	1,192 $12,000
Q1 2018 Apr 20, 2018	BUY	$6.7 - $12.95 $435 - $841	65 Added 13.1%	561 $5,000
Q4 2017 Jan 19, 2018	BUY	$5.07 - $7.92 $547 - $855	108 Added 27.84%	496 $3,000
Q2 2017 Nov 22, 2017	BUY	N/A	208 Added 115.56%	388 $2,000
Q4 2016 Nov 22, 2017	BUY	N/A	180	180 $0

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.